Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Small Intestinal Carcinoma
Drug:
gemcitabine
(
DNA synthesis inhibitor
) +
docetaxel
(
Tubulin polymerization promoter
,
Microtubule stabilizer
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Small Bowel Adenocarcinoma: Advanced or metastatic therapy regimens… Gemcitabine + docetaxel
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.